Hepatitis C Treatment
-
{
- All
- News
-
Pamela Anderson Was Told She Had 10 Years To Live: What Is Hepatitis C And Can It Be Cured?
- Wednesday September 9, 2026
- Health | Written by Sambhav Kumar
Pamela Anderson's hepatitis C journey highlights one of the major transformations in modern liver medicine. An infection that once involved years of uncertainty.
-
www.ndtv.com/health
-
How Hepatitis C Treatment Cost Can Be Reduced By Half
- Wednesday March 23, 2016
- Health | Indo-Asian News Service
The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.
-
www.ndtv.com/health
-
How Hepatitis C Treatment Cost Can Be Reduced By Half
- Wednesday March 23, 2016
- Health | Indo-Asian News Service
The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.
-
www.ndtv.com/health
-
Pamela Anderson Was Told She Had 10 Years To Live: What Is Hepatitis C And Can It Be Cured?
- Wednesday September 9, 2026
- Health | Written by Sambhav Kumar
Pamela Anderson's hepatitis C journey highlights one of the major transformations in modern liver medicine. An infection that once involved years of uncertainty.
-
www.ndtv.com/health
-
How Hepatitis C Treatment Cost Can Be Reduced By Half
- Wednesday March 23, 2016
- Health | Indo-Asian News Service
The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.
-
www.ndtv.com/health
-
How Hepatitis C Treatment Cost Can Be Reduced By Half
- Wednesday March 23, 2016
- Health | Indo-Asian News Service
The cost of treating Hepatitis C virus (HCV) could be reduced by half if doctors are trained to predict when a patient can safely stop taking the expensive but effective direct-acting antiviral (DAA) medication, suggests new research.
-
www.ndtv.com/health